6,8-Diprenylnaringenin

CAS No. 68236-11-3

6,8-Diprenylnaringenin( Lonchocarpol A | Senegalensin )

Catalog No. M29274 CAS No. 68236-11-3

6,8-Diprenylnaringenin is a natural product from hop Humulus lupulus. 6,8-Diprenylnaringenin is a breast cancer resistance protein(BCRP) inhibitor with some estrogenicity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    6,8-Diprenylnaringenin
  • Note
    Research use only, not for human use.
  • Brief Description
    6,8-Diprenylnaringenin is a natural product from hop Humulus lupulus. 6,8-Diprenylnaringenin is a breast cancer resistance protein(BCRP) inhibitor with some estrogenicity.
  • Description
    6,8-Diprenylnaringenin is a natural product from hop Humulus lupulus. 6,8-Diprenylnaringenin is a breast cancer resistance protein(BCRP) inhibitor with some estrogenicity.(In Vitro):6,8-Diprenylnaringenin inhibits ABCG2-mediated efflux of Mitoxantrone, and 3H-Methotrexate transport with an IC50 of 0.41 μM in HEK293 cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Lonchocarpol A | Senegalensin
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    BCRP
  • Recptor
    BCRP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    68236-11-3
  • Formula Weight
    408.5
  • Molecular Formula
    C25H28O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)=CCc1c(O)c(CC=C(C)C)c2O[C@@H](CC(=O)c2c1O)c1ccc(O)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Brevianamide F

    A naturally occurring 2,5-diketopiperazine that possess interesting breast cancer resistance protein (BCRP) inhibitory activity.

  • YHO-13177

    YHO-13177 is a acrylonitrile derivative and active form of YHO-13351 that can specifically reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo.

  • KS-176

    A potent and selective inhibitor of BCRP multidrug transporter with IC50 of 0.59 and 1.39 uM in Pheo A and Hoechst 33342 assays, respectively.